Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation |
KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung, Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary, Pulmonary Cancer, Pulmonary Neoplasms | Phase1, Phase2 | United States Netherlands Spain China Italy Japan Denmark Germany Hong Kong Belgium France Australia Canada Korea, Republic of Singapore Taiwan View All |
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake |
Neoplasms | Phase1, Phase2 | United Kingdom France United States Netherlands Austria Spain View All |
Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria |
Uncomplicated Plasmodium Falciparum Malaria | Phase3 | Congo, The Democratic Republic of the |
WOE of Anti-CD20 Therapies |
Multiple Sclerosis | United States | |
Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity |
Retinopathy of Prematurity | Korea, Republic of | |
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. |
C3G | Phase3 | United States Turkey Japan Greece Spain Brazil Switzerland Argentina United Kingdom Germany France Canada India Italy Netherlands Israel View All |
A Post Marketing Surveillance on Piqray in Korea |
Breast Cancer | Korea, Republic of | |
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world |
Breast Cancer | India | |
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis |
Multiple Sclerosis (MS) | Phase3 | United States Spain Serbia Germany Slovakia Romania Argentina Mexico Portugal Brazil Belgium Poland Guatemala Turkey Taiwan India France Chile United Kingdom Italy Canada Australia Israel Latvia Russian Federation Estonia Austria Croatia View All |
Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma. |
Melanoma | Turkey |